Bank of New York Mellon Corp purchased a new stake in Henry Schein, Inc. (NASDAQ: HSIC) in the undef

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Sc

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Henry Schein's broader growth, recurring technology revenues and savings plan support its outlook, b

Analysts changed outlook on top names. Piper Sandler raises Mercury Systems' target price, Ascen

BTIG analyst David Larsen maintains Henry Schein (NASDAQ:HSIC) with a Buy and raises the price ta

Henry Schein's stronger Q2 sales and margins prompt a 2026 outlook hike, but second-half savings exe

Empowered Funds LLC lessened its stake in Henry Schein, Inc. (NASDAQ: HSIC) by 59.2% during the firs

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and

Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Sc

Barclays analyst Glen Santangelo maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raise

UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the pri

Citigroup analyst Daniel Grosslight maintains Henry Schein (NASDAQ:HSIC) with a Buy and raises th

Henry Schein (HSIC) is at a 52-week high, but can investors hope for more gains in the future? We ta

Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call Transcript

Henry Schein NASDAQ: HSIC reported higher second-quarter sales, operating margins and earnings, citi

Henry Schein tops Q2 earnings and revenue estimates as internal sales growth accelerates and managem

While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business perf

Henry Schein (NASDAQ:HSIC) reported second-quarter financial results on Tuesday. The transcript from

Henry Schein (HSIC) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus

Henry Schein Inc (HSIC) released its 8-K filing on August 4, 2026, reporting impressive financial re

Henry Schein (NASDAQ:HSIC) raises FY2026 Adj EPS guidance from $5.23-$5.37 to $5.29-$5.39 vs $5.33 a

Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.27 per share which beat the analyst con

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of

California State Teachers Retirement System raised its position in Henry Schein, Inc. (NASDAQ: HSIC)

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC) announced today that it is creati

Piper Sandler analyst Jason Bednar maintains Henry Schein (NASDAQ:HSIC) with a Overweight and rai

UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the pri

BMO Capital initiates coverage on Henry Schein (NASDAQ:HSIC) with a Market Perform rating and anno

Wall Street analysts changed outlook on top names like MKTX, PRCT, VOD, and JILL. See ratings page a

Wall Street analysts change outlook for top stocks. See upgrades, downgrades, and initiations on ana

BTIG analyst David Larsen upgrades Henry Schein (NASDAQ:HSIC) from Neutral to Buy and announces $

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to offi

UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the pri

Mizuho analyst Steven Valiquette maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers t

Henry Schein (NASDAQ:HSIC) affirms FY2026 Adj EPS guidance from $5.23-$5.37 to $5.23-$5.37 vs $5.32

Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.32 per share which beat the analyst con

Morgan Stanley analyst Erin Wright maintains Henry Schein (NASDAQ:HSIC) with a Underweight and ra

Top analysts change outlook on top names, check analyst ratings page for all changes. Keybanc initia

Citigroup analyst Daniel Grosslight initiates coverage on Henry Schein (NASDAQ:HSIC) with a Buy r

Evercore ISI Group analyst Elizabeth Anderson maintains Henry Schein (NASDAQ:HSIC) with a Outperf

Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office

Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30%

Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperfor

UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the pri

JP Morgan analyst John Stansel maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises